Why the study?
Do platelet growth factors reduce severe thrombocytopenia and enhance platelet recovery in patients receiving chemotherapy or bone marrow transplantation?
Population
Patients receiving dose-intensive chemotherapy, treatment for leukemia, or bone marrow transplantation
Design
Review
Authors
Loading...
Cautious IL-11 use may be considered in chemotherapy thrombocytopenia; leaves open safer thrombopoietin analogues for leukemia and transplantation.
Do platelet growth factors reduce severe thrombocytopenia and enhance platelet recovery in patients receiving chemotherapy or bone marrow transplantation?
While platelet growth factors show promise in stimulating thrombopoiesis, significant obstacles remain, including mixed efficacy in certain clinical settings and the risk of inducing neutralizing antibodies.
Russell L. Basser (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: